History of:

* prior antiretroviral therapy

* significant drug hypersensitivity

* psychiatric illness that precludes compliance

* an active substance abuser

* positive test results for drug abuse

* abnormal lab test results (hemoglobin, absolute neutrophil count, platelet count, SGPT/AST or SGPT/ALT, creatinine, fasting triglycerides, significant abnormal ECG results

* pregnancy or lactating female

* received another investigational drug within 28 days of study initiation

* unlikely to comply or unsuitable candidate in the opinion of the investigator

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

What this study is about